Back
Greystone Housing Impact Investors LP Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
60
GHI
Greystone Housing Impact Investors LP
Last Price:
$12.87
Seasonality Move:
-0.92%
Buy
60
ALNY
Alnylam Pharmaceuticals
Last Price:
$280.77
Seasonality Move:
3.3%
Buy
60
Greystone Housing Impact Investors LP (GHI)
is a Buy
Is Greystone Housing Impact Investors LP a Buy, Sell or Hold?
-
The current Greystone Housing Impact Investors LP [GHI] share price is $12.95. The Score for GHI is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
GHI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GHI Stock Price Chart
What is Greystone Housing Impact Investors LP's stock price today?
-
The Greystone Housing Impact Investors LP share price today is $12.95The current trend is moderately bullish and GHI is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $290.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
GHI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 56.11 | Buy |
| Chaikin Money Flow: | 5504 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.41 - 12.99) | Buy |
| Bollinger Bands (100): | (11.15 - 12.67) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.72 | Buy |
| Relative Strength Index (14 RSI): | 71.41 | Buy |
| Chaikin Money Flow: | -979016 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (238.44 - 263) | Buy |
| Bollinger Bands (100): | (240.32 - 271.8) | Buy |
GHI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.93 | Buy |
| 20-day SMA: | 12.7 | Buy |
| 50-day SMA: | 12.38 | Buy |
| 200-day SMA: | 13.05 | Sell |
| 8-day EMA: | 12.92 | Buy |
| 20-day EMA: | 12.77 | Buy |
| 50-day EMA: | 12.44 | Buy |
| 200-day EMA: | 13.05 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 257.74 | Buy |
| 20-day SMA: | 249.75 | Buy |
| 50-day SMA: | 257.54 | Buy |
| 200-day SMA: | 251.5 | Buy |
| 8-day EMA: | 263.89 | Buy |
| 20-day EMA: | 256.08 | Buy |
| 50-day EMA: | 255.39 | Buy |
| 200-day EMA: | 243.44 | Buy |
Greystone Housing Impact Investors LP Earnings Growth & GHI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.03 per share, an increase this year of $0.19 per share, and an increase next year of $0.03 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Greystone Housing Impact Investors LP Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||